Camden Hebson1,2, Wendy Book1, Robert W. Elder3, Ryan Ford4, Maan Jokhadar1, Kirk Kanter5, Brian Kogon5, Adrienne H. Kovacs6, Rebecca D. Levit1, Michael Lloyd1, Kevin Maher2, Preeti Reshamwala4, Fred Rodriguez III1,2, Rene Romero7, Thor Tejada1, Anne Marie Valente8, Gruschen Veldtman9, Michael McConnell1,2
Congenital Heart Disease, Vol.12, No.1, pp. 6-16, 2017
Abstract “Frontiers in Fontan Failure” was the title of a 2015 conference sponsored by Children’s Healthcare of Atlanta and Emory University School of Medicine. In what is hoped to be the first of many
such gatherings, speakers and attendees gathered to discuss the problem of long-term clinical
deterioration in these patients. Specific focuses included properly defining the problem and then
discussing different treatment strategies, both medical and surgical. The health of the liver after
Fontan palliation was a particular point of emphasis, as were quality of life and future directions. More >
Login
Register
